(“CSPC”) (Stock Code: 1093.HK) jointly announced that biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003 has been granted another breakthrough therapy designation by the Center for Drug ...

Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT (fluorouracil, leucovorin, ...

Dr Anjali Pathak discusses four cases of skin cancer or pre-cancer - involving potentially malignant skin lesions - and their management ...

Aranscia® solutions help oncologists comply with new FDA warning label requiring  DPYD genetic testing in patients receiving select chemotherapies HOUSTON , Oct.

Durvalumab is currently approved for a number of cancer types. Though not approved in gastric cancer, the MATTERHORN regimen is currently under review by the FDA for the perioperative setting, with a ...

The HERCULES trial shows pembrolizumab plus chemotherapy produces a 39.4% response rate in advanced penile cancer, offering new treatment hope globally.

hUNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Sexual, Reproductive, Maternal, Child, Adolescent Health and ...

A new treatment for endometriosis is now available in New Zealand but it will set you back about $250 for a month's supply. Endometriosis is an inflammatory disease, with symptoms including period and ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...

Ultrasound has long been used for helping doctors see inside the body, but focused high frequency sound waves are offering new ways of targeting cancer. If Zhen Xu hadn't annoyed her lab mates, she ...

The FDA has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis, a rare, progressive lung disease that can cause scarring and breathing difficulties. The approval marks the ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Sean “Diddy” Combs was sentenced Friday to ...